Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
Public ClinicalTrials.gov record NCT00315640. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.
Study identification
- NCT ID
- NCT00315640
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- Anecortave Acetate Sterile Suspension, 6 mg/mL Drug
- Anecortave Acetate Suspension Depot, 30 mg/mL Drug
- Anecortave Acetate Sterile Suspension, 60 mg/mL Drug
- Anecortave Acetate Vehicle Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2005
- Primary completion
- Jun 30, 2009
- Completion
- Jun 30, 2009
- Last update posted
- Nov 27, 2012
2005 – 2009
United States locations
- U.S. sites
- 5
- U.S. states
- 3
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jacksonville | Jacksonville | Florida | 32204 | — |
| Miami | Miami | Florida | 33136 | — |
| Detroit | Detroit | Michigan | 48202 | — |
| Not listed | Fort Worth | Texas | 76134 | — |
| Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
Recently updated Eye Diseases trials
Other public records listing Eye Diseases. Sorted by last update posted; newest first. Not a recommendation.
- NCT02317328: Adaptive Optics Retinal Imaging Recruiting
- NCT00655096: Screening for Research Participants Recruiting
- NCT07413172: Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye Not yet recruiting
- NCT07322302: RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs) Recruiting
- NCT06841575: Advancing Pediatric Retinal Imaging With Auto-aligned OCT Recruiting
- NCT06891443: Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00315640, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2012 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00315640 live on ClinicalTrials.gov.